CD4 and neoplasm: In breast cancer mouse models, both SGJP and PA inhibit the numbers of MDSCs to increase the proportion of CD4+ T cells, CD8+ T cells, and NK cells in peripheral blood of mice, further improving the survival rates of mice and blocking tumor growth (Lu et al., 2017; Zheng et al., 2018) (Table 4).